NEW YORK — Australian diagnostics firm SpeeDx said on Tuesday that it has raised $15 million in new Series B funding.
The investment was made by Northpond Ventures, which last year invested $20 million in SpeeDx.
The firm will use the additional funds to support its product and services pipeline, SpeeDx CFO Bhavin Raval said in a statement.